Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation

2minutemedicine.com October 4, 2016

There was a total of 52 240 new starts of dabigatran and 66 651 new starts of rivaroxaban during the study period. Rivaroxaban was associated with a non-significant decrease in thromboembolic stroke. There was also a non-significant increase in mortality associated with rivaroxaban.

anticoagulation atrial fibrillation mortality risk stroke study

Impacts of Initial ICU Driving Pressure on Outcomes in Acute Hypoxemic Respiratory Failure

Effects of Surgery on Hemodynamics and Postoperative Delirium in Stanford Type A Aortic Dissection

Implementing a Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy Team Reduces Length of Stay and Hospital Costs

Predictors of Weaning Failure in Ventilated ICU Patients

Core Curriculum for Pain Management Nursing

Dottoressa: An American Doctor in Rome

Antiviral Drug Discovery and Development

Ultrasound Program Management

Nephrology Secrets

Critical Care Sedation

Case Files Emergency Medicine, Fourth Edition

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient

Severe Trauma and Sepsis: Organ Damage and Tissue Repair

Moderate and Deep Sedation in Clinical Practice

Basics of Mechanical Ventilation